
Spunweb Nonwoven Limited - IPO
SMESpunweb Nonwoven IPO Details
Spunweb Nonwoven IPO Dates
- 14 Jul 2025Opening dateOPD
- 16 Jul 2025Closing dateCOD
- 17 Jul 2025Basis of AllotmentBOA
- 18 Jul 2025Initiation of RefundsIOR
- 18 Jul 2025Credit of SharesCOS
- 21 Jul 2025Listing dateLID
Spunweb Nonwoven IPO Lot Size
Application | Lots | Shares | Amount |
---|---|---|---|
Individual Minimum | 2 | 2400 | ₹230,400 |
Individual Maximum | 2 | 2400 | ₹230,400 |
SHNI Minimum | 3 | 3600 | ₹345,600 |
SHNI Maximum | 8 | 9600 | ₹921,600 |
BHNI Minimum | 9 | 10800 | ₹1,036,800 |
Spunweb Nonwoven IPO Reservation
Promoter Holding
Documents
Spunweb Nonwoven IPO Valuations
Spunweb Nonwoven Limited Financial Information
Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
Assets | 182.76 | 106.58 | 93.15 |
Revenue | 227.14 | 154.24 | 117.68 |
Profit After Tax | 10.79 | 5.44 | 1.13 |
EBITDA | 31.23 | 15.01 | 10.80 |
Net Worth | 43.15 | 25.09 | 20.15 |
Reserves and Surplus | 27.30 | 15.77 | 10.33 |
Total Borrowing | 91.16 | 48.33 | 49.50 |
Amount in ₹ Crore |
About Spunweb Nonwoven IPO
Incorporated in 2015, Spunweb Nonwoven Limited is a manufacturer and supplier of non-woven fabrics, primarily used for applications like doormats, bags, carpets, and tarpaulins. They are recognized for their quality control system, which includes testing, inspection, and analysis to ensure high-quality products.
The company manufactures nonwoven fabric, laminated, and UV-treated nonwoven fabric.
The company operates state-of-the-art testing facilities, which include Universal Tensile Testing and Rewet Properties Testing.
The company exports its products to North America, Europe, and the Middle East. More than two-thirds of its revenue is generated from the demand for fabric in the hygiene sector, while the remaining portion is derived from applications in the medical, packaging, agriculture, and construction industries.
The company's clients include RGI Meditech Private Limited, Millenium Babycares Limited, Sekhani Industries Private Limited, Myra Hygiene Products Private Limited, Rotech Healthcare Private Limited, Poligof Micro Hygiene (India) Private Limited, Salus Products Private Limited, Kwalitex Healthcare Private Limited, JDS Nonwoven, Vyom Nonwoven, among others.
The company has exported its products to countries such as the United States of America, United Arab Emirates, Italy, Egypt, Saudi Arabia, Sri Lanka, Nepal, Kenya and Nigeria.
The company has a manufacturing facility situated in Rajkot, Gujarat.
Product Portfolio: Hydrophobic Fabric, Hydrophilic Fabric and UV-Treated Fabric.
As of May 31, 2025, the company had 199 employees.
Strength Of Spunweb Nonwoven IPO
1. We are one of the largest manufacturers of spunbond nonwoven fabrics in India.
2. We provide tailored spunbond nonwoven fabric manufacturing for industry specific needs.
3. Long standing association with different consumers in diverse industries and geographies.
4. Advanced spunbond technology along with cleanroom technology for manufacturing process.
5. Experienced Promoters supported by a strong management and execution team.
6. We ensure consistency in quality and service standards
7. Consistent financial performance.
Risk Of Spunweb Nonwoven IPO
1. Our Company and SIPL are dependent on limited number of suppliers for supply of raw materials and we have not made any long-term supply arrangement or agreement with our suppliers. In an eventuality where our suppliers are unable to deliver us the required materials, at a competitive price, in a time-bound manner it may have a material adverse effect on our business operations and profitability. The Majority of our raw materials are sourced from few key suppliers. Discontinuation of the operations of such suppliers may adversely affect our ability to source raw materials at a competitive price.
2. Our Company derive revenue from diversified customers whereas SIPL derives a significant portion of our revenue from a limited number of customers. Our inability to acquire new customers or loss of all or a substantial portion to any of our major customers, for any reason and/or continued reduction of the business from them, could have a material adverse impact on our business, results of operations, cash flows and financial condition.
3. Underutilization of the installed capacities at our Company and SIPL may impact adversely on our growth and future profitability.
4. We have significant working capital requirements and the objects of the Issue include funding working capital requirements of our Company and our wholly owned subsidiary SIPL, which is based on certain assumptions and estimates. Any failure in arranging adequate working capital for our operations may adversely affect our business, results of operations, cash flows and financial conditions.
5. We derive a significant portion of our revenue from operations from domestic sales which exposes us to risks specific to Indian geographies and market.
6. Our Company has negative cash flows from its investing activity and financing activity, details of which are given below. Sustained negative cash flow could adversely impact our business, financial condition and results of operations.
7. We are exposed to competition from both domestic and international manufacturers and new entrants and consequent pricing pressures could have a material adverse effect on our business growth and prospects, financial condition and results of operations.
8. Inventories and trade receivables form a major part of our current assets. Our inability to maintain a balance between optimum inventory levels and our product offering at our factory and failure to manage trade receivables may adversely affect our business, results of operations and financial condition.
9. Our historical performance is not indicative of our future growth or financial results, and we may not be able to sustain our historical growth rates or effectively execute our strategies, which may adversely affect our business and financial results.
10. Public health crises, such as pandemics, may disrupt operations and create fluctuating demand for hygiene and healthcare products, adversely impacting our business operations and financial performance.
Objectives Spunweb Nonwoven IPO
1. Funding the working capital requirements of the company
2. Investment in the wholly owned subsidiary, SIPL, for funding its working capital requirements
3. Repayment, in full or in part, of certain borrowings availed by the company
4. General Coporate Purposes
Company Contact Details
Spunweb Nonwoven Limited
Survey No.109(2), N.H. 27
Near Wankaner Boundry Post at Jalida,
Village Rangpar, Wankaner
Rajkot, Gujarat, 363621
Phone: +91-87 5894 4844
Email: cs@spunweb.in
Website: https://www.spunweb.com/
Registrar Contact Details
Lead Mangers
Vivro Financial Services Private Limited
Market Maker
Rikhav Securities